Adenoids provide a microenvironment for the generation of CD4(+), CD45RO(+), L-selectin(-), CXCR4(+), CCR5(+) T lymphocytes, a lymphocyte phenotype found in the middle ear effusion. NLM AIDSLINE Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Adenoids provide a microenvironment for the generation of CD4(+), CD45RO(+), L-selectin(-), CXCR4(+), CCR5(+) T lymphocytes, a lymphocyte phenotype found in the middle ear effusion.

Int Immunol. 2000 Sep;12(9):1235-43. Unique Identifier : AIDSLINE MED/20425414
Mattila PS; Nykanen A; Eloranta M; Tarkkanen J; Department of Otorhinolaryngology, Helsinki University Central; Hospital, Haartmaninkatu 4 E, 00290 Helsinki, Finland.


Abstract: Adenoidectomy in children with otitis media with effusion reduces inflammation in the middle ear by an unknown mechanism. Potentially, the adenoids of these children may serve as a site for the differentiation of lymphocytes, which after entering blood circulation eventually extravasate in the middle ear mucosa and thereby contribute to excessive inflammation. During lymphocyte extravasation various adhesion molecules and chemokines play a crucial role. To evaluate possible connections between the adenoids and middle ear inflammation, the expression of the chemokine receptors CXCR4 and CCR5 and the lymphocyte homing receptor L-selectin were analyzed in adenoidal and middle ear lymphocytes. It was found that most CD4(+) T lymphocytes in the middle ear effusion express the memory phenotype marker CD45RO and the chemokine receptors CXCR4 and CCR5, but are negative for the lymphocyte homing receptor L-selectin. This cell phenotype was rare in peripheral blood but was found much more frequently in the adenoids. The results suggest that the adenoids provide a microenvironment for the generation for CD4(+), CD45RO(+), L-selectin(-), CXCR4(+) and CCR5(+) T lymphocytes. Further, these cells may include cells that have the capacity to home to the middle ear mucosa. As the adenoidal CD4(+) memory phenotype CD45RO(+) T cells expressed the activation antigen CD69 and included cells expressing the HIV co-receptors CXCR4 and CCR5 at a high level, they may be permissive for HIV infection.


Keywords: JOURNAL ARTICLE Adenoids/*IMMUNOLOGY Antigens, CD/ANALYSIS Antigens, CD4/*ANALYSIS Antigens, CD45/*ANALYSIS Antigens, Differentiation, T-Lymphocyte/ANALYSIS Child Comparative Study Ear, Middle/*IMMUNOLOGY Flow Cytometry Human L-Selectin/*ANALYSIS Lymph Nodes/IMMUNOLOGY Otitis Media with Effusion/BLOOD/*IMMUNOLOGY Phenotype Receptors, CCR5/*ANALYSIS Receptors, CXCR4/*ANALYSIS Support, Non-U.S. Gov't T-Lymphocytes/DRUG EFFECTS/*IMMUNOLOGY

KWDjournalarticleadenoids/KWDimmunologyantigens,cd/analysisantigens,cd4/KWDanalysisantigens,cd45/KWDanalysisantigens,differentiation,t-lymphocyte/analysischildcomparativestudyear,middle/KWDimmunologyflowcytometryhumanl-selectin/KWDanalysislymphnodes/immunologyotitismediawitheffusion/blood/KWDimmunologyphenotypereceptors,ccr5/KWDanalysisreceptors,cxcr4/KWDanalysissupport,non-uKWDsKWDgov'tt-lymphocytes/drugeffects/KWDimmunology
001230
A00C0941


Copyright © 2000 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .